Skip to content

SynsoryBio

YC W24 · Active · "If-then" conditional logic for protein drugs

Competitors

Adjacent

Also from W24

All of W24

About SynsoryBio

SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.

YC batch
W24 · Winter 2024
Status, per YC
Active
Category
Other
Team size
2
Location
Boston, MA, USA
Checked
35m ago

YC tags: Synthetic Biology, Biotech, Therapeutics, Oncology

SynsoryBio in W24: 248 companies, 83% AI

SynsoryBio: questions

Which YC batch was SynsoryBio in?

SynsoryBio was in Y Combinator's Winter 2024 batch (W24).

Is SynsoryBio still active?

Y Combinator lists SynsoryBio as active.

Where is SynsoryBio based?

SynsoryBio lists Boston, MA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.